Cell & Gene: The Podcast
Erin Harris
Outreach Signals
Publishing Details
About This Podcast
Podcasting 2.0 Features
Social Media
Explore Statistics
Recent Episodes
Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers
We love to hear from our listeners. Send us a message.In Episode 3 of our in vivo-focused special series of Cell & Gene: The Podcast, Ascidian Therapeutics' Founder, President, and CEO Mike…
Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.
We love to hear from our listeners. Send us a message.In episode 2 of this four-part in vivo-focused special series of Cell & Gene: The Podcast, Host Erin Harris sits down with Gopi Shanker,…
Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics’ Dr. Naji Gehchan
We love to hear from our listeners. Send us a message.In episode 130 of Cell & Gene: The Podcast, Dr. Naji Gehchan, Chief Medical and Development Officer at Kyverna Therapeutics, joins Host Erin…
The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.
We love to hear from our listeners. Send us a message.This is Episode 1 of a four-episode in vivo-focused special series of Cell & Gene: The Podcast. Host Erin Harris speaks with Cassie Gorsuch,…
Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts
We love to hear from our listeners. Send us a message.In episode 129 of Cell & Gene: The Podcast, Host Erin Harris reconnects with Zachary Roberts, M.D., Ph.D., EVP of Research & Development…
Building Integrated cGMP Systems for Autologous Cell Therapies with MassGen's Tatyana Matveeva, Ph.D.
We love to hear from our listeners. Send us a message.In episode 128, Host Erin Harris talks to Tatyana Matveeva, Ph.D., Director of cGMP Operations at George A. "Doc" Lopez, MD Laboratory for…
Rewriting Disease Biology Through LSD1 Inhibition with Oryzon's Carlos Buesa, Ph.D.
We love to hear from our listeners. Send us a message.On Episode 127 of Cell & Gene: The Podcast, Carlos Buesa, Ph.D., Founder and Chairman of the Board at Oryzon talks to Host Erin Harris about…
Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.
We love to hear from our listeners. Send us a message.On episode 126 of Cell & Gene: The Podcast, Host Erin Harris welcomes Catriona Jamieson, M.D., Ph.D, Director of the UC San Diego Sanford…
Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka
We love to hear from our listeners. Send us a message.On episode 125 of Cell & Gene: The Podcast, Host Erin Harris talks to Halloran Consulting Group's Monika Swietlicka to discuss how the FDA is…
Scaling CRISPR for Rare Disease with Aurora Therapeutics' Dr. Edward Kaye
We love to hear from our listeners. Send us a message.On episode 124 of Cell & Gene: The Podcast, Aurora Therapeutics' CEO Dr. Edward Kaye discusses the company’s strategy for translating CRISPR…
Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous
We love to hear from our listeners. Send us a message.In episode 123 of Cell & Gene: The Podcast, Host Erin Harris talks to Dr. Panteli Theocharous, FIBMS, M.S., Ph.D., FRCPath, about the patient…
Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness
We love to hear from our listeners. Send us a message.In episode 122 of Cell & Gene: The Podcast, Host Erin Harris talks to Paul Romness, CEO of OS Therapies, to learn the company’s mission to…
Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes
We love to hear from our listeners. Send us a message.In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO and Co-Founder Benjamin Oakes about building…
Advancing Off-the-Shelf CRISPR CAR-T Therapies into the Community Setting with Caribou Biosciences' Rachel Haurwitz
We love to hear from our listeners. Send us a message.Welcome to episode 120 of Cell & Gene: The Podcast. Host Erin Harris is joined by Rachel Haurwitz, CEO of Caribou Biosciences, to discuss the…
The Editors' Roundtable: A 2025 Retrospective of the Life Science Industry
We love to hear from our listeners. Send us a message.We’re sharing this Better Biopharma episode on Cell & Gene: The Podcast because Better Biopharma is a sister show in the Life Science Connect…
Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki
We love to hear from our listeners. Send us a message.In episode 119 of Cell & Gene The Podcast, Host Erin Harris talks to Dr. Norman Putzki, Global Head Clinical Development, Novartis, about the…
Turning the Tumor Microenvironment Against Cancer with MGB's Alexander Cryer, Ph.D.
We love to hear from our listeners. Send us a message.In Episode 118, Host Erin Harris talks to Alexander Cryer, Ph.D., Instructor in Medicine at Mass General Brigham, about a proof of concept…
Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault
We love to hear from our listeners. Send us a message.On episode 117, Host Erin Harris welcomes Paul Perreault, Strategic Advisor, Board Member and former CEO of CSL, who shares insights from his…
Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay
We love to hear from our listeners. Send us a message.In episode 116 of Cell & Gene: The Podcast, Host Erin Harris talks to Dr. Arun Upadhyay, Chief Scientific officer, Head of Research and…
Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer
We love to hear from our listeners. Send us a message.Episode 115 of Cell & Gene: The Podcast features Host Erin Harris' talk with Aliya Omer, Vice President and Global Head of Hematology and…
Frequently Asked Questions
Cell & Gene: The Podcast has published 139 episodes since June 2021, covering topics in Life Sciences, Science.
Cell & Gene: The Podcast is currently highly active with new episodes every 2 weeks. Average episode length is 25m.
